Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.77
(-0.83%)
CNY 4.77
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 328.97 Million | 339.49 Million | 257.12 Million | 162.55 Million | 295.62 Million | 267.67 Million |
| Net Income | 234.4 Million | 200.82 Million | -609.59 Million | 205.77 Million | 293.03 Million | -359.93 Million |
| Depreciation & Amortization | 209.06 Million | 184.43 Million | 174.29 Million | 155.77 Million | 143.97 Million | 140.77 Million |
| Deferred income taxes | 22.78 Million | -24.27 Million | -4.9 Million | -7.2 Million | -6.41 Million | 1.75 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -89.3 Million | -63.75 Million | -113.48 Million | -176.67 Million | -112.5 Million | -120.89 Million |
| Other non-cash items | 25.44 Million | 18 Million | 805.9 Million | -22.31 Million | -28.86 Million | 607.71 Million |
| Investing Cash Flow | -93.62 Million | -440 Million | -349.23 Million | -316.83 Million | -274.96 Million | 12.66 Million |
| Investments in PPE | -215.67 Million | -383.1 Million | -413.03 Million | -344.53 Million | -223.79 Million | -132.16 Million |
| Acquisitions | 122.66 Million | 4.28 Million | -1 Million | -201.16 Million | 82.72 Million | -10.17 Million |
| Investment purchases | -50.35 Million | -159.72 Million | -159.98 Million | -889.1 Million | -1.36 Billion | -1.55 Billion |
| Sales/Maturities of investments | 54.64 Million | 62.2 Million | 218.33 Million | 952.84 Million | 1.32 Billion | 1.69 Billion |
| Other Investing Activities | -4.9 Million | 36.32 Million | 6.45 Million | 165.11 Million | -100.29 Million | 17.76 Million |
| Financing Cash Flow | 46.25 Million | -171.67 Million | 211.41 Million | 326.98 Million | 31.1 Million | -39.03 Million |
| Debt repayment | -142.79 Million | -801.36 Million | -663 Million | -205.22 Million | -137 Million | -87 Million |
| Dividends payments | -59.48 Million | -28.09 Million | -59.48 Million | -59.48 Million | -2.37 Million | -120.38 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.56 Million | 657.77 Million | 958.51 Million | 604.9 Million | 170.48 Million | 81.35 Million |
| Accounts receivables | 71.85 Million | -78.5 Million | -68.26 Million | -75.09 Million | -50.43 Million | -42.62 Million |
| Accounts payables | -193.14 Million | 159.87 Million | 24.98 Million | 24.92 Million | -15.43 Million | -18.31 Million |
| Inventory | 9.2 Million | -120.85 Million | -65.29 Million | -119.29 Million | -40.2 Million | -61.71 Million |
| Other working capital | 4.79 Million | -24.27 Million | -4.9 Million | -7.2 Million | -6.41 Million | -59.17 Million |
| Cash at beginning of period | 654.05 Million | 923.32 Million | 806.19 Million | 647.22 Million | 595.16 Million | 352.62 Million |
| Cash at end of period | 936.54 Million | 654.05 Million | 923.32 Million | 806.19 Million | 647.22 Million | 595.16 Million |
| Capital Expenditure | -215.67 Million | -383.1 Million | -413.03 Million | -344.53 Million | -223.79 Million | -132.16 Million |
| Effect of forex changes on cash | 878.46 Thousand | 2.91 Million | -2.16 Million | -13.72 Million | 288.43 Thousand | 1.22 Million |
| Net cash flow / Change in cash | 282.48 Million | -269.27 Million | 117.13 Million | 158.96 Million | 52.06 Million | 242.53 Million |
| Free Cash Flow | 113.29 Million | -43.6 Million | -155.9 Million | -181.98 Million | 71.83 Million | 135.51 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.12 Million | 93.97 Million | 122.5 Million | -19.97 Million | 234.4 Million | 90.95 Million |
| Depreciation & Amortization | - | 49.03 Million | 49.03 Million | 61.35 Million | 209.06 Million | -86.5 Million |
| Deferred income taxes | - | - | - | - | 22.78 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -90.94 Million | - | 85.84 Million | -89.3 Million | 101.36 Million |
| Other non-cash items | -31.58 Million | 89.82 Million | 32.33 Million | 242.93 Million | 25.44 Million | 12.72 Million |
| Investing Cash Flow | -84.86 Million | -9.18 Million | -96.04 Million | 49.08 Million | -93.62 Million | -26.15 Million |
| Investments in PPE | -50.33 Million | -51.41 Million | -65.02 Million | -75.91 Million | -215.67 Million | -34.68 Million |
| Acquisitions | 148.45 Thousand | 52.12 Thousand | 130.02 Thousand | 114.53 Million | 122.66 Million | 440.02 Thousand |
| Investment purchases | -50 Million | -40 Million | - | -5 Million | -50.35 Million | -13 Million |
| Sales/Maturities of investments | 20.04 Million | 41.99 Million | 5.25 Million | 15.47 Million | 54.64 Million | 21.12 Million |
| Other Investing Activities | -4.58 Million | 185.25 Thousand | -36.4 Million | -17 Thousand | -4.9 Million | -22.99 Thousand |
| Financing Cash Flow | 4.78 Million | -116.26 Million | -101.6 Million | -98.91 Million | 46.25 Million | -135.16 Million |
| Debt repayment | -13.65 Million | -46.92 Million | -92.68 Million | -81.5 Million | -142.79 Million | -215.88 Million |
| Dividends payments | -5.35 Million | -64.79 Million | -8.73 Million | -14.82 Million | -59.48 Million | -6.4 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.52 Million | -4.54 Million | -181.99 Thousand | -2.58 Million | -2.56 Million | 87.12 Million |
| Accounts receivables | - | -25.35 Million | - | 71.85 Million | 71.85 Million | 27.69 Million |
| Accounts payables | - | - | - | - | -193.14 Million | - |
| Inventory | - | -65.58 Million | - | 9.2 Million | 9.2 Million | 73.67 Million |
| Other working capital | - | - | - | 4.79 Million | 4.79 Million | - |
| Cash at beginning of period | 861.38 Million | 893.77 Million | 936.54 Million | 825.09 Million | 654.05 Million | 867.69 Million |
| Cash at end of period | 834.84 Million | 861.38 Million | 893.77 Million | 936.54 Million | 936.54 Million | 825.09 Million |
| Capital Expenditure | -50.33 Million | -51.41 Million | -65.02 Million | -75.91 Million | -215.67 Million | -34.68 Million |
| Effect of forex changes on cash | 43.56 Thousand | 293.4 Thousand | 303.5 Thousand | 148 Thousand | 878.46 Thousand | 287.27 Thousand |
| Net cash flow / Change in cash | -26.54 Million | -32.38 Million | -42.77 Million | 111.44 Million | 282.48 Million | -42.6 Million |
| Free Cash Flow | 3.21 Million | 83.35 Million | 89.8 Million | 85.69 Million | 113.29 Million | 83.85 Million |
PNLF
5946
TMAS
ORBTEXP
RECO
PTM